IPA (ImmunoPrecise) Kacepetan wutah bathi saben saham ing taun lumaku
ImmunoPrecise Antibodies (IPA) leads in AI-driven antibody creation, accelerating target discovery and expanding its partnership network. High demand for computational screening fuels current growth while new catalysts mature. A technological moat and patent protection distinguish the company from traditional laboratories. The year-over-year EPS percentage deviation confirms the success of the model, where the 83.10 indicator determines the metric's magnitude.
Rincian metrik keuangan lan pasar immunoprecise.com (IPA)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Koefisien Total Utang marang Modal ImmunoPrecise Antibodies|IPA - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal ImmunoPrecise Antibodies Ltd.|IPA - Gunggung utang perusahaan|Rasio utang marang aset resik ImmunoPrecise Antibodies Ltd.|IPA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ImmunoPrecise Antibodies|Rasio likuiditas darurat immunoprecise.com
- data bathi resik lan rasio valuasi:
IPA - Penghasilan resik|Bathi resik mangsa ngarep ImmunoPrecise Antibodies|IPA - Pangali P/E|Kapitalisasi marang proyeksi bathi ImmunoPrecise Antibodies Ltd.|IPA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ImmunoPrecise Antibodies Ltd.|IPA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan ImmunoPrecise Antibodies|IPA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan immunoprecise.com|IPA - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep ImmunoPrecise Antibodies
Ringkesan analisis perusahaan:ImmunoPrecise (IPA)
Analyzing earnings per share (EPS) growth relative to the previous year is critical for finding the balance between business quality and market valuation. This metric measures net income growth rates, determining real capital efficiency and a company's resilience to market shocks. In the case of ImmunoPrecise Antibodies (IPA), high B2B customer loyalty driven by AI integrations ensures the stability of this growth, which is clearly evidenced by tracking annual EPS growth.
Pesaing langsung
Tempus Labs - Tambahing bathi saben saham ing taun lumaku|QGEN (Qiagen Group) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Isis Pharmaceuticals IONS|Wutah bathi ing taun lumaku RGEN|Wutah bathi resik saben saham ing taun iki aviditybiosciences.com RNA|Wutah bathi ing taun lumaku CRSP (CRISPR Therapeutics)|Prakiraan wutah bathi resik saben saham ing taun iki GeneDx Holdings (WGS)|RARE - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Beam Tx BEAM|SRPT: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku twistbioscience.com (TWST)|Wutah bathi resik saben saham ing taun iki TXG|NTLA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku STOK|Wutah bathi ing taun lumaku BioLife (BLFS)|Wutah bathi saben saham ing taun lumaku Wave Life Sciences WVE|MAZE: Wutah bathi saben saham ing taun iki|SION: Wutah bathi resik saben saham ing taun iki|Prime Medicine Inc - Wutah bathi resik saben siji saham kanggo taun lumaku|TSHA: Wutah bathi ing taun lumaku|QURE - Prakiraan wutah bathi resik saben saham ing taun iki|MGTX (MeiraGTx Holdings plc) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku RGNX|Wutah bathi saben saham ing taun lumaku Solid Biosciences (SLDB)|OCGN - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku PACB (Pacific Biosciences of California)|BNTC: Wutah bathi saben saham ing taun iki|Design Therapeutics - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki rocketpharma.com RCKT|FDMT: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Lexeo Therapeutics, Inc. (LXEO)|Wutah bathi saben saham ing taun lumaku Korro Bio Inc.|Editas Corp (EDIT) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku SLN|Prakiraan wutah bathi resik saben saham ing taun iki proqr.com|Wutah bathi saben saham ing taun lumaku Codexis CDXS|SGMO (Sangamo Therapeutics Inc.) - Dinamika bathi saben saham ing taun lumaku|Nautilus Biotechnology Inc - Wutah bathi ing taun lumaku|MGX - Wutah bathi ing taun lumaku|DTIL: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki GBIO|Wutah bathi saben saham ing taun lumaku Boundless Bio|Wutah bathi saben saham ing taun iki XCUR (Exicure Corp)|Wutah bathi ing taun lumaku IMNN|Wutah bathi ing taun lumaku phiopharma.com (PHIO)|Wutah bathi ing taun lumaku MBIO (Mustang Bio)|Prakiraan wutah bathi resik saben saham ing taun iki TransCode Therapeutics Inc. (RNAZ)|BNGO - Wutah bathi saben saham ing taun lumaku|Applied DNA Sciences Inc (APDN) - Wutah bathi resik saben saham ing taun iki|Bluebird Bio (BLUE) - Wutah bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki Omega Therapeutics Corp|Wutah bathi resik saben saham ing taun iki OMIC|Wutah bathi ing taun lumaku regulusrx.com|Wutah bathi saben saham ing taun lumaku Syros Pharmaceuticals, Inc. (SYRS)|Telesis Bio Inc. - Wutah bathi saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku TRACON TCON|Unity Biotechnology, Inc (UBX) - Kacepetan wutah bathi saben saham ing taun lumaku
